Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 18/20 | 0.75 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.75 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.75 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.75 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.75 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.75 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.75 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.75 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.75 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.75 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | NCOR2 | Q9Y618 | 3/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19609252 | 0.90 | HDAC1 (0.66) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL19609254 | 0.89 | HDAC1 (0.65) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL3813600 | 0.86 | HDAC1 (1.00) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL8079556 | 0.86 | PLK1 (0.71) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL22798202 | 0.86 | HDAC1 (0.70) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL27608822 | 0.86 | HDAC1 (0.65) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL2135459 | 0.86 | HDAC1 (0.65) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL674399 | 0.86 | HDAC1 (0.75) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL14473033 | 0.85 | HDAC1 (0.68) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL28155970 | 0.85 | HDAC1 (0.64) | HDAC1HDAC3HDAC2HDAC8HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023734-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2009-01-22 | — | — | US | disclosed |
| US-20090023734-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2009-01-22 | — | — | US | disclosed |
| US-20090023734-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2009-01-22 | — | — | US | disclosed |
| US-7282608-B2 | Inhibitors of histone deacetylase | METHYLGENE, INC. (CA) | 2007-10-16 | — | — | US | disclosed |
| US-7282608-B2 | Inhibitors of histone deacetylase | METHYLGENE, INC. (CA) | 2007-10-16 | — | — | US | disclosed |
| US-7282608-B2 | Inhibitors of histone deacetylase | METHYLGENE, INC. (CA) | 2007-10-16 | — | — | US | disclosed |
| US-20060020131-A1 | Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents | METHYLGENE, INC. (CA) | 2006-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023734-A1 | INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC11, HDAC6 | HDAC1 1/4885HDAC3 5/4885HDAC2 6/4885 |
| US-20060020131-A1 | Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents | HDAC1, AADAC, HDAC11 | HDAC1 1/4885HDAC3 6/4885HDAC2 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.